Science Explorer Interactive view Map
Company · Cambridge · United States

Ribon Therapeutics (United States)

ribontx.comROR OpenAlex
Research works
42
▲ 340% vs 2013–17
Citations
915
22.0 per fractional work
Top-10% rate
17.4%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: Ribon Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.13× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.63× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 5.14× its world share, 1 worksImmunology and Micro…Neuroscience: 0.46× its world share, 0 worksNeuroscienceEngineering: 0.07× its world share, 0 worksEngineeringMathematics: 1.37× its world share, 0 worksMathematicsPhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyMedicine: 3.60× its world share, 9 worksMedicineEconomics, Econometrics and Finance: 0.90× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.1×. Every wedge is a field page.

Which keywords describe research at Ribon Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Cell Death, Homologous Recombination, Synthetic Lethality, BRCA Mutation, PARP Inhibitors, Tumor Microenvironment and Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Cancer Therapy11▲ 42×7 topics
  2. Cell Death10▲ 120×3 topics
  3. Homologous Recombination10▲ 353×2 topics
  4. Synthetic Lethality10▲ 931×2 topics
  5. BRCA Mutation10▲ 1356×1 topic
  6. PARP Inhibitors10▲ 1356×1 topic
  7. Cancer3▲ 5.7×14 topics
  8. Tumor Microenvironment3▲ 21×6 topics
  9. Inflammation3▲ 2.7×14 topics
  10. Antigen Presentation2▲ 53×2 topics
  11. Epidemiology2▲ 1.24×12 topics
  12. Innate Immunity2▲ 12×4 topics
  13. Failure Analysis2▲ 29×1 topic
  14. Integrated Circuits2▲ 17×1 topic
  15. Angiogenesis2▲ 9.0×5 topics
  16. Cancer Immunotherapy2▲ 26×2 topics
  17. Immunity2▲ 11×3 topics
  18. Dendritic Cells1▲ 28×1 topic
  19. Immune Checkpoint Blockade1▲ 59×1 topic
  20. PD-1 and PD-L11▲ 59×1 topic
  21. Risk Factors1▲ 3.2×3 topics
  22. Tumor Antigen1▲ 40×1 topic
  23. Catheter-Related Infections1▲ 91×1 topic
  24. Central Venous Catheterization1▲ 91×1 topic
  25. Antimicrobial Resistance1▲ 9.5×2 topics
  26. Monoclonal Antibodies1▲ 17×2 topics
  27. Transcriptional Regulation1▲ 9.7×4 topics

Which research topics does Ribon Therapeutics (United States) publish most on?

By volume in 2022–2025: PARP inhibition in cancer therapy, Cancer Immunotherapy and Biomarkers, Cell Adhesion Molecules Research and Ferroptosis and cancer prognosis.

PARP inhibition in cance…2PARP inhibition in cancer therapy: 2 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksCell Adhesion Molecules …1Cell Adhesion Molecules Research: 1 fractional worksFerroptosis and cancer prognosis: 0 fractional worksAntimicrobial Resistance in Staphylococcus: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksCancer-related gene regulation: 0 fractional worksDrug-Induced Adverse Reactions: 0 fractional worksBiological Research and Disease Studies: 0 fractional worksMedical Imaging Techniques and Applications: 0 fractional works
OncologyImmunology and AllergyPulmonary and Respiratory MedicineInfectious Diseases3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 PARP inhibition in cancer therapy Oncology 2 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 Cell Adhesion Molecules Research Immunology and Allergy 1 works
  4. 4 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  5. 5 Antimicrobial Resistance in Staphylococcus Infectious Diseases 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Cancer-related gene regulation Molecular Biology 0 works
  8. 8 Drug-Induced Adverse Reactions Pharmacology 0 works
  9. 9 Biological Research and Disease Studies Molecular Biology 0 works
  10. 10 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.4%not open50.6%

World: 28% of research is openly available.

with international co-authors23.0%domestic only77.0%

World: 19% is written across borders.

How has Ribon Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 340% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.